Iron Park Capital Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-179,434	Closed	-$1.79M	–	46
2022 Q1	$1.79M	Buy	179,434 +117,218	+188%	+$1.17M	1.51%	25
2021 Q4	$615K	Buy	+62,216	New	+$615K	0.49%	36